PS ratio:
N/ASummary
- CDTX price to sales ratio is not available.
Performance
CDTX PS ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
PS ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
CDTX PS ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | - | +0.2% | +0.2% | -100.0% |
| 1 m1 month | - | -0.6% | -0.6% | - |
| 3 m3 months | - | +193.4% | +473.7% | -100.0% |
| 6 m6 months | - | +191.2% | +574.1% | - |
| ytdytd | - | +141.3% | +458.9% | - |
| 1 y1 year | - | +457.6% | +1909.0% | -100.0% |
| 5 y5 years | - | -0.5% | +1074.2% | -100.0% |
CDTX PS ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | 3621.57 | 902.73 | ||
| 6 m | 6-month | 3621.57 | 178.95 | ||
| 1 y | 1-year | 3621.57 | 5.71 | ||
| 3 y | 3-year | 3621.57 | 0.56 | ||
| 5 y | 5-year | 3621.57 | 0.54 | ||
| alltime | all time | 3621.57 | 0.54 |
CDTX PS ratio History
| Date | Value |
|---|---|
| 2024 | 230.78(>+9900.0%) |
| 2023 | 1.67(+96.5%) |
| 2022 | 0.85(-51.1%) |
| Date | Value |
|---|---|
| 2021 | 1.74(-76.6%) |
| 2020 | 7.44(+19.8%) |
| 2019 | 6.21 |
FAQ
- What is the all time high PS ratio for Cidara Therapeutics, Inc.?
What is the all time high PS ratio for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high price to sales ratio is 3621.57